SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Leppik IE, Kramer LD, Bourgeois B. et al Felbamate after withdrawal of other epileptic drugs [Abstract]. Neurology 1990; 40:158.
  • 2
    Perhach JL, Weliky I, Newton, JJ. et al Felbamate. In: MeldrumBM, PorterRJ. eds. New anticonvulsant drugs. London , Paris : I. Libbey, 1986: 11723.
  • 3
    Pellock JM, Watemberg N. New antiepileptic drugs in children: present and future. Semin Pediatr Neurol 1997; 4: 918.
  • 4
    Pellock JM, Brodie MJ. Felbamate: 1997 update. Epilepsia 1997; 38: 12614.
  • 5
    Brodie MJ, Pellock JM. Taming the brain storms: felbamate updated. Lancet 1995; 346: 9189.
  • 6
    Bourgeois BFD. Felbamate. Semin Pediatr Neurol 1997; 4: 38.
  • 7
    White HS, Harmsworth WL, Sofia RD. et al Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Res 1995; 20: 418.
  • 8
    Ticku MK, Kamatchi GL, Sofia RD. Effect of anticonvulsant felbamate on GABA-receptor system. Epilepsia 1991; 32: 38991.
  • 9
    Rho JM, Donevan DC, Rogawski MA. Mechanism of action of the anticonvulsant felbamate: opposing effects on NMDA and GABAA receptors. Ann Neurol 1994; 35: 22934.
  • 10
    Shumaker RC, Fantel C, Kelton E. et al Evaluation of the elimination of [14C] felbamate in healthy men [Abstract]. Epilepsia 1990; 31:642.
  • 11
    Sachdeo RC, Narang-Sachdeo SK, Howard JR. et al Steady-state pharmacokinetics and dose proportionality of felbamate after oral administration of 1200, 2400, and 3600 mg/day of felbamate. Epilepsia 1993; 34:80.
  • 12
    Ward DL, Shumaker RC. Comparative bioavailability of felbamate in healthy men [Abstract]. Epilepsia 1990; 31:642.
  • 13
    Sachdeo R, Wagner M, Sachdeo S. et al Steady-state pharmacokinetics of phenytoin when co-administered with FelbatolTM (felbamate). Epilepsia 1992; 33(suppl 3):84.
  • 14
    Hooper WD, Franklin ME, Glue P. et al Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of β-oxidation. Epilepsia 1996; 37: 917.
  • 15
    Howard JR, Dix RK, Shumaker RC. et al Effect of felbamate on carbamazepine pharmacokinetics. Epilepsia 1992; 33(suppl 3):845.
  • 16
    Wagner ML, Graves NM, Marineau K. et al Discontinuation of phenytoin and carbamazepine in patients receiving felbamate. Epilepsia 1991; 32: 398406.
  • 17
    Leppik IE, Dreifuss FR, Pledger GW. et al Felbamate for partial seizure: results of a controlled clinical trial. Neurology 1991; 41: 17859.
  • 18
    Bourgeois B, Leppik IE, Sackellares JC. et al Felbamate: a double-blind trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993; 43: 6936.
  • 19
    Sachdeo R, Kramer LD, Rosenberg A. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992; 32: 38692.
  • 20
    Felbamate Study Group in Lennox-Gastaut syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993; 328:2933.
  • 21
    Dodson WE. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month, open-label study following a randomized clinical trial. Epilepsia 1993;34(suppl 7):S1824.
  • 22
    Sachdeo RC, Murphy JV, Kamin M. Felbamate in juvenile myoclonic epilepsy. Epilepsia 1992; 33(suppl 3):84.
  • 23
    Hosain S, Nagarajan L, Carson D. et al Felbamate for refractory infantile spasms. J Child Neurol 1997; 12: 4668.
  • 24
    Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. J Child Neurol 1995; 10: 1346.
  • 25
    Kaufman DW, Kelly JP, Anderson T. et al Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997; 38: 12659.
  • 26
    Pellock JM. The place of felbamate in epilepsy therapy: evaluating the risks. Drug Safety 1999 [in press].
  • 27
    Pellock JM. Carbamazepine side-effects in children and adults. Epilepsia 1987; 28:S6470.
  • 28
    Bryant AE, Dreifuss FR. Valproic acid hepatic failures: US experience since 1986. Neurology 1996; 46: 4658.
  • 29
    Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991; 41: 9614.
  • 30
    Pellock JM, Felbamate: current practice opinions [Abstract]. Neurology 1996; 46:A175.
  • 31
    Thompson CD, Gulden PH, Macdonald TL. Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration. Chem Res Toxicol 1997; 10: 45762.
  • 32
    Kapetanovic IM, Torchin CD, Thompson CD. et al A potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro. Drug Metab Disp 1998; 26: 10891095.